Literature DB >> 20697605

ADAM metallopeptidase domain 33 (ADAM33): identification and role in airways disease.

Stephen T Holgate1.   

Abstract

Asthma is a common disorder of the airways which exhibit variable obstruction associated with hyperresponsiveness linked to altered smooth muscle. Although environmental factors are important in the origins and progression of asthma, it is a disorder with high heritability. The identification of ADAM33 (ADAM metallopeptidase domain 33, a disintegrin and metalloproteinase domain 33) as the first novel asthma gene has implications for the mechanisms of airway hyper-responsiveness and airway wall remodeling. This review discusses the molecular regulation of ADAM33, its link to asthma and chronic obstructive pulmonary disease and newly identified functions. These all point to ADAM33 being a key molecule in the development and progression of asthma by contributing to smooth muscle and vascular modeling and remodeling. Copyright 2010 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697605     DOI: 10.1358/dnp.2010.23.6.1437242

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  8 in total

Review 1.  The genetics of asthma and allergic disease: a 21st century perspective.

Authors:  Carole Ober; Tsung-Chieh Yao
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

2.  Optical biosensing of markers of mucosal inflammation.

Authors:  Obdulia Covarrubias-Zambrano; Massoud Motamedi; Bill T Ameredes; Bing Tian; William J Calhoun; Yingxin Zhao; Allan R Brasier; Madumali Kalubowilage; Aruni P Malalasekera; Asanka S Yapa; Hongwang Wang; Christopher T Culbertson; Deryl L Troyer; Stefan H Bossmann
Journal:  Nanomedicine       Date:  2021-11-04       Impact factor: 6.096

3.  TGF-β1 stimulates epithelial-mesenchymal transition mediated by ADAM33.

Authors:  Liping Fang; Jie Wu; Tao Huang; Pengpeng Zhang; Xiaofeng Xin; Yi Shi
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

4.  ADAM33 gene polymorphisms and mortality. A prospective cohort study.

Authors:  Sylwia M Figarska; Judith M Vonk; Cleo C van Diemen; Dirkje S Postma; H Marike Boezen
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

5.  Association of ADAM33 gene polymorphisms with asthma in the Uygur population of China.

Authors:  Jing Wang; Jin Wen; Mi-He-Re-Gu-Li Si-Ma-Yi; Yuan-Bing He; Ke-Li-Bie-Na Tu-Er-Xun; Yu Xia; Jian-Long Zhang; Qi-Man-Gu-Li Wu-Shou-Er
Journal:  Biomed Rep       Date:  2013-03-11

6.  Association study on ADAM33 polymorphisms in mite-sensitized persistent allergic rhinitis in a Chinese population.

Authors:  Ruo-Xi Chen; Wen-Min Lu; Lu-Ping Zhu; Mei-Ping Lu; Mei-Lin Wang; Yun-Li Wang; Xin-Yuan Chen; Xin-Jie Zhu; Min Yin; Zheng-Dong Zhang; Lei Cheng
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 7.  Asthma Endotyping and Biomarkers in Childhood Asthma.

Authors:  Amelia Licari; Riccardo Castagnoli; Ilaria Brambilla; Alessia Marseglia; Maria Angela Tosca; Gian Luigi Marseglia; Giorgio Ciprandi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2018-06-01       Impact factor: 1.349

8.  ADAM33 polymorphisms are associated with asthma and a distinctive palm dermatoglyphic pattern.

Authors:  Weilin Xue; Wei Han; Zhao-Shan Zhou
Journal:  Mol Med Rep       Date:  2013-10-14       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.